Cargando…
Applicability and Eligibility of the International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) for Patients who Underwent Revascularization with Percutaneous Coronary Intervention
In the International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial, an early invasive strategy did not decrease mortality compared to a conservative strategy for stable ischemic heart disease (SIHD) patients with moderate-to-severe ischemia, and the...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564619/ https://www.ncbi.nlm.nih.gov/pubmed/32906673 http://dx.doi.org/10.3390/jcm9092889 |
_version_ | 1783595756077187072 |
---|---|
author | Niimi, Nozomi Sawano, Mitsuaki Ikemura, Nobuhiro Nagai, Toshiyuki Nakano, Shintaro Shoji, Satoshi Shiraishi, Yasuyuki Ueda, Ikuko Numasawa, Yohei Suzuki, Masahiro Noma, Shigetaka Fukuda, Keiichi Kohsaka, Shun |
author_facet | Niimi, Nozomi Sawano, Mitsuaki Ikemura, Nobuhiro Nagai, Toshiyuki Nakano, Shintaro Shoji, Satoshi Shiraishi, Yasuyuki Ueda, Ikuko Numasawa, Yohei Suzuki, Masahiro Noma, Shigetaka Fukuda, Keiichi Kohsaka, Shun |
author_sort | Niimi, Nozomi |
collection | PubMed |
description | In the International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial, an early invasive strategy did not decrease mortality compared to a conservative strategy for stable ischemic heart disease (SIHD) patients with moderate-to-severe ischemia, and the role of revascularization would be revised. However, the applicability and potential influence of this trial in daily practice remains unclear. Our objective was to assess the eligibility and representativeness of the ISCHEMIA trial on the patients with percutaneous coronary intervention (PCI). From a multicenter registry, we extracted a consecutive 13,223 SIHD patients with PCI (baseline cohort). We applied ISCHEMIA eligibility criteria and compared the baseline characteristics between the eligible patients and the actual study participants (randomized controlled trial (RCT) patients). In 3463 patients with follow-up information (follow-up cohort), the 2 year composite of major adverse cardiac events was evaluated between the eligible patients and RCT patients, as well as eligible and non-eligible patients in the registry. In the baseline cohort, 77.3% of SIHD patients with moderate-to-severe ischemia were eligible for the ISCHEMIA. They were comparable with RCT patients for baseline characteristics and outcomes unlike the non-eligible patients. In conclusion, the trial results seem applicable for the majority of PCI patients with moderate-to-severe ischemia except for the non-eligible patients. |
format | Online Article Text |
id | pubmed-7564619 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-75646192020-10-29 Applicability and Eligibility of the International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) for Patients who Underwent Revascularization with Percutaneous Coronary Intervention Niimi, Nozomi Sawano, Mitsuaki Ikemura, Nobuhiro Nagai, Toshiyuki Nakano, Shintaro Shoji, Satoshi Shiraishi, Yasuyuki Ueda, Ikuko Numasawa, Yohei Suzuki, Masahiro Noma, Shigetaka Fukuda, Keiichi Kohsaka, Shun J Clin Med Article In the International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial, an early invasive strategy did not decrease mortality compared to a conservative strategy for stable ischemic heart disease (SIHD) patients with moderate-to-severe ischemia, and the role of revascularization would be revised. However, the applicability and potential influence of this trial in daily practice remains unclear. Our objective was to assess the eligibility and representativeness of the ISCHEMIA trial on the patients with percutaneous coronary intervention (PCI). From a multicenter registry, we extracted a consecutive 13,223 SIHD patients with PCI (baseline cohort). We applied ISCHEMIA eligibility criteria and compared the baseline characteristics between the eligible patients and the actual study participants (randomized controlled trial (RCT) patients). In 3463 patients with follow-up information (follow-up cohort), the 2 year composite of major adverse cardiac events was evaluated between the eligible patients and RCT patients, as well as eligible and non-eligible patients in the registry. In the baseline cohort, 77.3% of SIHD patients with moderate-to-severe ischemia were eligible for the ISCHEMIA. They were comparable with RCT patients for baseline characteristics and outcomes unlike the non-eligible patients. In conclusion, the trial results seem applicable for the majority of PCI patients with moderate-to-severe ischemia except for the non-eligible patients. MDPI 2020-09-07 /pmc/articles/PMC7564619/ /pubmed/32906673 http://dx.doi.org/10.3390/jcm9092889 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Niimi, Nozomi Sawano, Mitsuaki Ikemura, Nobuhiro Nagai, Toshiyuki Nakano, Shintaro Shoji, Satoshi Shiraishi, Yasuyuki Ueda, Ikuko Numasawa, Yohei Suzuki, Masahiro Noma, Shigetaka Fukuda, Keiichi Kohsaka, Shun Applicability and Eligibility of the International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) for Patients who Underwent Revascularization with Percutaneous Coronary Intervention |
title | Applicability and Eligibility of the International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) for Patients who Underwent Revascularization with Percutaneous Coronary Intervention |
title_full | Applicability and Eligibility of the International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) for Patients who Underwent Revascularization with Percutaneous Coronary Intervention |
title_fullStr | Applicability and Eligibility of the International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) for Patients who Underwent Revascularization with Percutaneous Coronary Intervention |
title_full_unstemmed | Applicability and Eligibility of the International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) for Patients who Underwent Revascularization with Percutaneous Coronary Intervention |
title_short | Applicability and Eligibility of the International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) for Patients who Underwent Revascularization with Percutaneous Coronary Intervention |
title_sort | applicability and eligibility of the international study of comparative health effectiveness with medical and invasive approaches (ischemia) for patients who underwent revascularization with percutaneous coronary intervention |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564619/ https://www.ncbi.nlm.nih.gov/pubmed/32906673 http://dx.doi.org/10.3390/jcm9092889 |
work_keys_str_mv | AT niiminozomi applicabilityandeligibilityoftheinternationalstudyofcomparativehealtheffectivenesswithmedicalandinvasiveapproachesischemiaforpatientswhounderwentrevascularizationwithpercutaneouscoronaryintervention AT sawanomitsuaki applicabilityandeligibilityoftheinternationalstudyofcomparativehealtheffectivenesswithmedicalandinvasiveapproachesischemiaforpatientswhounderwentrevascularizationwithpercutaneouscoronaryintervention AT ikemuranobuhiro applicabilityandeligibilityoftheinternationalstudyofcomparativehealtheffectivenesswithmedicalandinvasiveapproachesischemiaforpatientswhounderwentrevascularizationwithpercutaneouscoronaryintervention AT nagaitoshiyuki applicabilityandeligibilityoftheinternationalstudyofcomparativehealtheffectivenesswithmedicalandinvasiveapproachesischemiaforpatientswhounderwentrevascularizationwithpercutaneouscoronaryintervention AT nakanoshintaro applicabilityandeligibilityoftheinternationalstudyofcomparativehealtheffectivenesswithmedicalandinvasiveapproachesischemiaforpatientswhounderwentrevascularizationwithpercutaneouscoronaryintervention AT shojisatoshi applicabilityandeligibilityoftheinternationalstudyofcomparativehealtheffectivenesswithmedicalandinvasiveapproachesischemiaforpatientswhounderwentrevascularizationwithpercutaneouscoronaryintervention AT shiraishiyasuyuki applicabilityandeligibilityoftheinternationalstudyofcomparativehealtheffectivenesswithmedicalandinvasiveapproachesischemiaforpatientswhounderwentrevascularizationwithpercutaneouscoronaryintervention AT uedaikuko applicabilityandeligibilityoftheinternationalstudyofcomparativehealtheffectivenesswithmedicalandinvasiveapproachesischemiaforpatientswhounderwentrevascularizationwithpercutaneouscoronaryintervention AT numasawayohei applicabilityandeligibilityoftheinternationalstudyofcomparativehealtheffectivenesswithmedicalandinvasiveapproachesischemiaforpatientswhounderwentrevascularizationwithpercutaneouscoronaryintervention AT suzukimasahiro applicabilityandeligibilityoftheinternationalstudyofcomparativehealtheffectivenesswithmedicalandinvasiveapproachesischemiaforpatientswhounderwentrevascularizationwithpercutaneouscoronaryintervention AT nomashigetaka applicabilityandeligibilityoftheinternationalstudyofcomparativehealtheffectivenesswithmedicalandinvasiveapproachesischemiaforpatientswhounderwentrevascularizationwithpercutaneouscoronaryintervention AT fukudakeiichi applicabilityandeligibilityoftheinternationalstudyofcomparativehealtheffectivenesswithmedicalandinvasiveapproachesischemiaforpatientswhounderwentrevascularizationwithpercutaneouscoronaryintervention AT kohsakashun applicabilityandeligibilityoftheinternationalstudyofcomparativehealtheffectivenesswithmedicalandinvasiveapproachesischemiaforpatientswhounderwentrevascularizationwithpercutaneouscoronaryintervention |